Prevalence of vitamin D deficiency in HIV-positive, antiretroviral treatment-naïve patients in a single centre study

International Journal of STD and AIDS

Volumn 25, Issue 7, 2014, Pages 488-492

  Gedela, Keerti ^a   Edwards, Simon G ^b   Benn, Paul ^b   Grant, Alison D ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b CENTRAL AND NORTH WEST LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

25 hydroxycholecalciferol; AIDS; antiretroviral therapy; bone metabolism; HIV; hypocalcaemia; hypovitaminosis; vitamin D deficiency

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CALCIFEDIOL; CALCIUM; 25-HYDROXYVITAMIN D; VITAMIN D;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTUMN; CALCIUM BLOOD LEVEL; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; ETHNICITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOCALCEMIA; HYPOPHOSPHATEMIA; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPRING; SUMMER; UNITED KINGDOM; VIRUS LOAD; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WINTER; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; ENGLAND; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIDDLE AGED; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LONDON; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; VIRAL LOAD; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84900398575     PISSN: 09564624     EISSN: 17581052     Source Type: Journal    
DOI: 10.1177/0956462413515194     Document Type: Article

References (24)

1. Tahrani AA,Ball A,Shepherd L,et al.The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK.Int J Clin Pract. 2010;64:351-355.
2. Cheng S,Massaro JM,Fox CS,et al.Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study.Diabetes. 2010;59:242-248.
3. Judd SE,Tangpricha V.Vitamin D deficiency and risk for cardiovascular disease.Am J Med Sci. 2009;338:40-44.
4. Kilkkinen A,Knekt P,Aro A,et al.Vitamin D status and the risk of cardiovascular disease death.Am J Epidemiol. 2009;170:1032-1039.
5. Pearce SHS,Cheetham TD.Diagnosis and management of vitamin D deficiency.BMJ. 2010;340:b5664-b5664.
6. Yamshchikov AV,Desai NS,Blumberg HM,et al.Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials.Endocr Pract. 2009;15:438-449.
7. Martineau AR,Honecker FU,Wilkinson RJ,et al.Vitamin D in the treatment of pulmonary tuberculosis.J Steroid Biochem Mol Biol. 2007;103:793-798.
8. Ustianowski A,Shaffer R,Collin S,et al.Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London.J Infect. 2005;50:432-437.
9. Villamor E.A potential role for vitamin D on HIV infection?.Nutr Rev. 2006;64:226-233.
10. Fox J,Peters B,Prakash M,et al.Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trial.AIDS Res Hum Retroviruses. 2011;27:29-34.
11. Yin M.Vitamin D, bone, and HIV infection.Top Antivir Med. 2012;20:168-172.
12. Mehta S,Hunter DJ,Mugusi FM,et al.Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania.J Infect Dis. 2009;200:1022-1030.
13. Mehta S,Giovannucci E,Mugusi FM,et al.Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality.PLoS ONE. 2010;5:e8770-e8770.
14. Ross AC,Judd S,Kumari M,et al.Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals.Antivir Ther (Lond). 2011;16:555-563.
15. Ansemant T,Mahy S,Piroth C,et al.Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients.BMC Infect Dis. 2013;13:7-7.
16. Rosenvinge MM,Gedela K,Copas AJ,et al.Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency.J Acquir Immune Defic Syndr. 2010;54:496-499.
17. Welz T,Childs K,Ibrahim F,et al.Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase.AIDS. 2010;24:1923-1928.
18. Mueller NJ,Fux CA,Ledergerber B,et al.High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients.AIDS. 2010;24:1127-1134.
19. Ford L,Graham V,Wall A,et al.Vitamin D concentrations in an UK inner-city multicultural outpatient population.Ann Clin Biochem. 2006;43:468-473.
20. Brown TT,McComsey GA.Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D.Antivir Ther (Lond). 2010;15:425-429.
21. Cozzolino M,Vidal M,Arcidiacono MV,et al.HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D.AIDS. 2003;17:513-520.
22. Bouvier G.Protease inhibitors can interfere with vitamin D metabolism.HIV Clin. 2009;21:9-10.
23. Klassen K,Martineau AR,Wilkinson RJ,et al.The effect of tenofovir on vitamin D metabolism in HIV-infected adults is dependent on sex and ethnicity.PLoS ONE. 2012;7:e44845-e44845.
24. Childs K,Welz T,Samarawickrama A,et al.Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patients.AIDS. 2012;26:253-262.